Sabra Health Care REIT (NASDAQ:SBRA) Issues Quarterly Earnings Results, Misses Expectations By $0.24 EPS


Share on StockTwits

Sabra Health Care REIT (NASDAQ:SBRA) issued its quarterly earnings results on Sunday. The real estate investment trust reported $0.18 EPS for the quarter, missing the consensus estimate of $0.42 by ($0.24), MarketWatch Earnings reports. Sabra Health Care REIT had a return on equity of 4.15% and a net margin of 23.42%.

Shares of SBRA traded down $0.26 during mid-day trading on Tuesday, hitting $18.18. 1,838,161 shares of the company’s stock were exchanged, compared to its average volume of 1,373,779. The company has a market cap of $3.76 billion, a price-to-earnings ratio of 26.55 and a beta of 1.49. Sabra Health Care REIT has a fifty-two week low of $5.55 and a fifty-two week high of $22.47. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.01 and a current ratio of 1.01. The stock’s 50-day moving average is $17.42 and its 200-day moving average is $16.08.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 26th. Stockholders of record on Friday, February 12th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Thursday, February 11th. This represents a $1.20 annualized dividend and a dividend yield of 6.60%. Sabra Health Care REIT’s dividend payout ratio is presently 64.52%.

Several equities research analysts recently commented on the stock. Smith Barney Citigroup boosted their price target on shares of Sabra Health Care REIT from $14.00 to $17.00 in a report on Tuesday, December 15th. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $24.00 target price for the company in a report on Thursday, December 3rd. Zacks Investment Research lowered shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a report on Tuesday, January 26th. Mizuho lowered shares of Sabra Health Care REIT from a “buy” rating to a “neutral” rating and set a $18.00 target price for the company. in a report on Wednesday, January 13th. Finally, Citigroup Inc. 3% Minimum Coupon Principal Protected Based Upon Russell boosted their price target on shares of Sabra Health Care REIT from $14.00 to $17.00 in a research report on Tuesday, December 15th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. Sabra Health Care REIT has an average rating of “Hold” and an average target price of $17.08.

Sabra Health Care REIT Company Profile

As of September 30, 2020, Sabra's investment portfolio included 425 real estate properties held for investment (consisting of (i) 287 Skilled Nursing/Transitional Care facilities, (ii) 64 Senior Housing communities (ÂSenior Housing – LeasedÂ), (iii) 47 Senior Housing communities operated by third-party property managers pursuant to property management agreements (ÂSenior Housing – ManagedÂ) and (iv) 27 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a direct financing lease, 19 investments in loans receivable (consisting of (i) one mortgage loan, (ii) one construction loan and (iii) 17 other loans), six preferred equity investments and one investment in an unconsolidated joint venture that owns 158 Senior Housing – Managed communities.

Featured Story: What are the benefits of momentum investing?

Earnings History for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.